Related references
Note: Only part of the references are listed.Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future
Piero Parchi et al.
ACTA NEUROPATHOLOGICA (2011)
Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay
Julie Ann Edgeworth et al.
LANCET (2011)
Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion
Ryuichiro Atarashi et al.
NATURE MEDICINE (2011)
Decreased CSF Transferrin in sCJD: A Potential Pre-Mortem Diagnostic Test for Prion Disorders
Ajay Singh et al.
PLOS ONE (2011)
Structural and mechanistic commonalities of amyloid-β and the prion protein
Bianca Da Costa Dias et al.
PRION (2011)
The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review
G. Chohan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease
I. Zerr et al.
BRAIN (2009)
Bayes' theorem and diagnostic tests in neuropsychology: Interval estimates for post-test probabilities
John R. Crawford et al.
CLINICAL NEUROPSYCHOLOGIST (2009)
Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients
Ines Esteves Baldeiras et al.
JOURNAL OF NEUROLOGY (2009)
Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies
Anna Ladogana et al.
JOURNAL OF NEUROLOGY (2009)
The diagnostic utility of multiple-level likelihood ratios
Stephen C. Bowden et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2009)
14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes
K. Gmitterova et al.
NEUROBIOLOGY OF AGING (2009)
Rapidly progressive dementia
Michael D. Geschwind et al.
ANNALS OF NEUROLOGY (2008)
Biological and methodological features of the measurement of S100B, a putative marker of brain injury
Carlos-Alberto Goncalves et al.
CLINICAL BIOCHEMISTRY (2008)
Spectrum bias-why clinicians need to be cautious when applying diagnostic test studies
Brian H. Willis
FAMILY PRACTICE (2008)
Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease
Peter Brechlin et al.
PROTEOMICS (2008)
Cautionary tales in the clinical interpretation of studies of diagnostic tests
I. A. Scott et al.
INTERNAL MEDICINE JOURNAL (2008)
Cerebrospinal fluid markers in Creutzfeldt-Jakob disease
Anders Skinningsrud et al.
FLUIDS AND BARRIERS OF THE CNS (2008)
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease
P. Sanchez-Juan et al.
NEUROLOGY (2006)
Creutzfeldt-Jakob disease: A rare cause of dementia in elderly persons
R Knight
CLINICAL INFECTIOUS DISEASES (2006)
Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD
Natividad Cuadrado-Corrales et al.
BMC NEUROLOGY (2006)
14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan
K Satoh et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2006)
Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada
A Ladogana et al.
NEUROLOGY (2005)
Refining clinical diagnosis with likelihood ratios
DA Grimes et al.
LANCET (2005)
Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: Implications for use in clinical practice
NSM Schoonenboom et al.
CLINICAL CHEMISTRY (2005)
Rationale for diagnosing human prion disease
GG Kovács et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2004)
A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease
B Van Everbroeck et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease
MD Geschwind et al.
ARCHIVES OF NEUROLOGY (2003)
Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation
SA Mulherin et al.
ANNALS OF INTERNAL MEDICINE (2002)
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease
M Otto et al.
NEUROLOGY (2002)
Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease
AJ Aksamit et al.
NEUROLOGY (2001)
CSF detection of the 14-3-3 protein in unselected patients with dementia
PR Burkhard et al.
NEUROLOGY (2001)
14-3-3 testing in diagnosing Creutzfeldt-Jakob disease - A prospective study in 112 patients
AW Lemstra et al.
NEUROLOGY (2000)
Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid
S Collins et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2000)
Share Paper
